This document summarizes information about Zika virus infection in pregnancy from several sources:
- Zika virus is transmitted by Aedes mosquitoes and was first isolated in Uganda in 1947. Recent outbreaks have occurred in French Polynesia, Brazil and other parts of the Americas.
- Brazil reported an increase in infants born with microcephaly in 2015 which was linked to Zika virus infection during pregnancy after the virus was detected in amniotic fluid and brain tissue of affected fetuses and infants.
- The CDC provides testing and screening guidelines for pregnant women with travel history or residence in areas with Zika virus transmission to monitor infections and potential fetal impact.
3. Zika virus
• Zika virus, a flavivirus
transmitted by Aedes
mosquitoes.
Schuler-Faccini et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
4. CLINICAL ILLNESS
CONSISTENT WITH ZIKA
VIRUS DISEASE
• Two or more of the following
signs or symptoms:
– Acute onset of fever
– Maculopapular rash
– Arthralgia
– Conjunctivitis
@helenvmadamba POGS CEBU 2016
5. • Zika virus (ZIKV), a mosquito-borne
flavivirus, was first isolated from a rhesus
monkey in Uganda in 1947.
Hayes EB 2009 at http://wwwnc.cdc.gov/eid
@helenvmadamba POGS CEBU 2016
6. • ZIKV was isolated from humans in Nigeria
during studies conducted in 1968 and during
1971-1975.
Hayes EB 2009 at http://wwwnc.cdc.gov/eid
@helenvmadamba POGS CEBU 2016
7. • From 1951 through 1981, serologic
evidence of human ZIKV infection reported
• African countries such as Uganda,
Tanzania, Egypt, Central African Republic,
Sierra Leone, and Gabon
• Parts of Asia including India, Malaysia,
Philippines, Thailand, Vietnam, and
Indonesia
Hayes EB 2009 at http://wwwnc.cdc.gov/eid
@helenvmadamba POGS CEBU 2016@helenvmadamba POGS CEBU 2016
8. • Discovery of ZIKV on the
physically isolated community
of Yap island is testimony to
the potential for travel or
commerce to spread the virus
across large distances.
Hayes EB 2009 at http://wwwnc.cdc.gov/eid
• The outbreak on Yap island, Micronesia in
2007 shows that ZIKV illness has been
detected outside of Africa and Asia.
@helenvmadamba POGS CEBU 2016
9. Since January 2012, the Pacific Region has
experienced 28 new documented outbreaks and
circulation of dengue, chikungunya and Zika virus.
Roth A et.al. 2016 at http://www.eurosurveillance.org
@helenvmadamba POGS CEBU 2016
10. Map of newly reported dengue, chikungunya and Zika virus infection
outbreaks or new virus circulation, Pacific Region,
January 2012–17 September 2014 (n=28)
Roth A et.al. 2016 at http://www.eurosurveillance.org
@helenvmadamba POGS CEBU 2016
11. Map of the known distribution of Aedes (Stegomyia) mosquitoes, vectors
of dengue and possible vectors of chikungunya and
Zika viruses, Pacific Region as of beginning October 2014
Roth A et.al. 2016 at http://www.eurosurveillance.org
@helenvmadamba POGS CEBU 2016
12. • Largest ZIKV outbreak occurred in French
Polynesia during 2013-2014.
Musso 2016 at http://wwwnc.cdc.gov/eid
@helenvmadamba POGS CEBU 2016
13. Brazil strain = French Polynesia
• Imported cases from French
Polynesia
• Occurred among attendees of the
annual Tapati festival
• World Cup Soccer competition in
2014
• Va’a World Sprint Championship
canoe race in Rio de Janeiro
Musso 2016 at http://wwwnc.cdc.gov/eid
@helenvmadamba POGS CEBU 2016
15. MARCH 2012
• A prospective longitudinal cohort
study, which included active
surveillance for acute febrile
illness, was initiated in Cebu
City, Philippines.
– 270 acute febrile illnesses
– 267 samples for serologic testing
for evidence of influenza, dengue,
chikungunya, Japanese
encephalitis, and Zika virus
infections
Alera MT et.al. 2015 at http://wwwnc.cdc.gov/eid
@helenvmadamba POGS CEBU 2016
16. MAY 2012
• A 15-year old boy in Cebu City
• subjective fever, headache,
conjunctivitis, sore throat,
myalgias, stomach pain,
anorexia, nausea and vomiting,
but no rash
• The boy recovered fully by the 3-
week study follow up visit.
• ZIKV RNA was detected in the
patient’s serum sample
Alera MT et.al. 2015 at http://wwwnc.cdc.gov/eid
@helenvmadamba POGS CEBU 2016
17. • It is possible that the ZIKV strain
was introduced into the
Philippines before 2012 and
remained undetected.
Alera MT et.al. 2015 at http://wwwnc.cdc.gov/eid
@helenvmadamba POGS CEBU 2016
18. Why the fuss now?
• Rapid spread since its first detection
in May 2015 in Brazil to 22 other
countries and other territories in the
Americas
• Possible association with a significant
rise in the number of babies born with
microcephaly and neurological
disorders
• “Global Emergency” by the WHO
Petersen E et.al. 2016 at http://wwwnc.cdc.gov/eid
@helenvmadamba POGS CEBU 2016
20. In Brazil November 2014: great outbreak of a
new exanthematic disease characterized by
early onset exanthema, no or little fever,
arthraligia, articular edema and conjunctivitis
Zika virus confirmed through PCR in April 2015.
@helenvmadamba POGS CEBU 2016
21. On January 22, this report was posted as an MMWR
Early Release on the MMWR website
@helenvmadamba POGS CEBU 2016
22. September 2015
• Increase in the number of infants
born with microcephaly in Zika
virus-affected areas began to
emerge.
Schuler-Faccini et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
23. Microcephaly
• Head circumference ≥ 2
standard deviations [SD] below
the mean for sex and gestational
age at birth
Schuler-Faccini et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
24. October 2015
• The Ministry of Health (MoH) confirmed
an increase in birth prevalence of
microcephaly in northeast Brazil,
compared with previously reported
estimates (approx 0.5/10,000 LB)
• 58 cases in a single month from different
cities
• MICROCEPHALY REGISTRY in Brazil
established
Brito C. 2015 at http://www.actamedicaportuguesa.com
@helenvmadamba POGS CEBU 2016
25. Brazilian Society of
Medical Genetics
• Zika Embryopathy Task Force
(SBGM-ZETF) includes clinical
geneticists, obstetricians,
pediatricians, neurologists and
radiologists
• Objective: to review all incident cases
of microcephaly as well as infants
born to mothers with suspected Zika
virus infections during pregnancy
Schuler-Faccini et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
26. Brazil Ministry of Health
• Cohort of 35 infants with
microcephaly born August to
October 2015
– 35 mothers lived in or visited Zika
virus-affected areas during pregnancy
– 25 infants had severe micrcephaly
– 17 had at least one neurologic
abnormality
– 27 infants who had neuroimaging
studies, all had abnormalities
Schuler-Faccini et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
27. Brazil Ministry of Health
• Pregnant women should protect
themselves from mosquito bites:
– By using airconditioning, screens, or
nets when indoors
– Wearing long sleeves and pants
– Using permethrin-treated clothing and
gear
– Using insect repellants when
outdoors
r
Schuler-Faccini et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
28. Increase in microcephaly
associated with ZIKV
• Outbreak of many cases in short
space of time in different cities
high attack rates and rapid
dispersion transmitted by
arthropods
Brito C. 2015 at http://www.actamedicaportuguesa.com
@helenvmadamba POGS CEBU 2016
29. Increase in microcephaly
associated with ZIKV
• Microcephaly, periventricular and
cortical microcalcifications, vernix
cerebellar hypoplasia and
lisencephaly compatible with
congenital infections
Brito C. 2015 at http://www.actamedicaportuguesa.com
@helenvmadamba POGS CEBU 2016
30. Increase in microcephaly
associated with ZIKV
• Diseases associated with TORCH not
associated with large outbreaks
• Negative for TORCH infections
• 70% mothers reported compatible
features of Zika disease in first
trimester of pregnancy (during
outbreak)
Brito C. 2015 at http://www.actamedicaportuguesa.com
@helenvmadamba POGS CEBU 2016
31. Zika virus genome was detected in amniotic fluid
samples from two pregnant women in Brazil whose
fetuses had been diagnosed with microcephaly.
Calvet et al 2016 at http://www.thelancet.com
@helenvmadamba POGS CEBU 2016
32. Zika Viral RNA and antigens were detected in
brain tissues from infants with microcephaly and
placental tissues from early miscarriages.
Martines et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
35. On January 19, 2016 this report was posted as an MMWR
Early Release on the MMWR website
@helenvmadamba POGS CEBU 2016
36. Health care providers should ask
all pregnant women about recent
travel.
• (+) symptoms consistent with
Zika virus transmission with
ultrasound findings of fetal
microcephaly or intracranial
calcifications test for Zika
Petersen et.al. 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
37. • Testing is not indicated for
women without travel history to
an area with Zika virus
transmission.
Petersen et.al. 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
38. Pregnant women with laboratory
evidence of Zika virus infection
• serial ultrasound examination to
monitor fetal growth and
anatomy
• referral to maternal-fetal
medicine or infectious disease
specialist.
– There is no specific antiviral
treatment for Zika virus, supportive
care is recommended
Petersen et.al. 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
39. On January 26, 2016, this report was posted as an MMWR
Early Release on the MMWR website
@helenvmadamba POGS CEBU 2016
40. Zika virus testing
• Infants with microcephaly or
intracranial calcifications born to
women who traveled to or resided
in an area with Zika virus
transmission while pregnant
• Infants born to mothers with
positive or inconclusive test
results for Zika virus infection
Staples JE et.al. 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
41. Zika virus testing
• Molecular
• serologic
Staples JE et.al. 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
42. Zika virus testing
• As an arboviral disease, Zika
virus disease is a nationally
notifiable condition.
Staples JE et.al. 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
43. Staples JE et.al. 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
44. Staples JE et.al. 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
45. On February 5, 2015, this report was posted as an MMWR
Early Release on the MMWR website
@helenvmadamba POGS CEBU 2016
47. With clinical illness consistent
with Zika virus disease
• Reverse transcription-PCR
testing (RT-PCR)
• Immunoglobulin M (IgM)
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
48. Asymptomatic pregnant women
• Serologic testing for Zika virus
– Consider cross-reactivity among
dengue, yellow fever and West
Nile viruses
– Negative IgM obtained 2-12 weeks
after travel would suggest a recent
infection did not occur and could
obviate need for serial ultrasounds.
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
50. Recommendation
• Includes recommendations for
screening, testing, and
management of pregnant
women and recommendations
for counseling women of
reproductive age (15–44 years)
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
52. • Pregnant women who reside in
areas with ongoing Zika virus
transmission have an ongoing
risk for infection throughout their
pregnancy and should be
evaluated for symptoms of Zika
virus disease.
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
54. (+) clinical illness
• Testing by RT-
PCR on serum
collected
within 7 days
of symptom
onset
@helenvmadamba POGS CEBU 2016
55. Women who report clinical
illness consistent with Zika
virus disease
• A negative RT-PCR result from
serum collected 5-7 days after
symptom onset does not exclude
Zika virus infection
• Serologic testing should be
performed.
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
56. • A false positive IgM result is
more likely among women
residing in areas with ongoing
Zika virus transmission than
among travelers because of a
higher likelihood of previous
exposure to a related flavivirus.
Serologic testing
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
57. (-) clinical illness
• Testing
recommended at
the initiation of
prenatal care with
follow-up testing
mid-second
trimester
– Local levels of Zika
virus transmission
– Laboratory
capacity
@helenvmadamba POGS CEBU 2016
58. Pregnant women with
negative Zika virus IgM
• Routine prenatal care
• Ultrasound should include
careful evaluation of the fetus for
brain anomalies, including
microcephaly and intracranial
calcifications (late second and
early third trimesters of
pregnancy)
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
59. Pregnant women with
positive or inconclusive
Zika virus IgM
• Referral to maternal-fetal
medicine specialist
• Serial fetal ultrasounds to
monitor fetal anatomy and
growth every 3-4 weeks
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
60. At the time of delivery
• histopathologic examination of
the placenta and umbilical cord,
• testing of frozen placental tissue
and cord tissue for Zika virus
RNA, and
• testing of cord serum
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
61. • To prevent human-to-mosquito-
to-human transmission, persons
infected with Zika, dengue, or
chikungunya virus should protect
themselves from mosquito
exposure during the first week of
illness.
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
63. • Health care providers should
discuss reproductive life plans,
including pregnancy intention
and timing, with women of
reproductive age in the context
of the potential risks associated
with Zika virus infection.
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
64. Pregnancy intentions
and timing
• Patient age
• Fertility
• Reproductive and medical history
• Values and preferences of the woman and
her partner
• Discussion of the signs and symptoms and
potential risks associated with Zika virus
infection
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
65. Strategies to prevent
unintended pregnancy
• Counseling on family planning
• Safety, effectiveness, availability,
acceptability considered when
selecting a contraceptive method
• Correct and consistent use of
condoms reduces the risk for
sexually transmitted infections
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
66. • Women of reproductive age with
current or previous laboratory-
confirmed Zika virus infection
should be counseled that there
is no evidence that prior Zika
virus infection poses a risk for
birth defects in future
pregnancies.
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
67. • Viremia is expected to last
approximately one week in
patients with clinical illness.
• There is no current evidence to
suggest that a fetus conceived
after maternal viremia has
resolved would be at risk for fetal
infection.
Oduyebo et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
68. On February 5, 2015, this report was posted as an MMWR
Early Release on the MMWR website
@helenvmadamba POGS CEBU 2016
69. Sexual transmission of Zika
virus is possible
• From man to woman in
Colorado, USA
• From man to woman in Dallas
County Health and Human
Services
• Replication-competent Zika virus
isolated from semen
Oster AM et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
70. • Clinical and serologic evidence indicate that 2
American scientists contracted Zika virus
infections while working in Senegal in 2008.
• One of the scientists transmitted this
arbovirus to his wife after his return home.
• Direct contact is implicated as the
transmission route, most likely as a sexually
transmitted infection.
Foy et.al. 2011 at http://www.ncbi.nlm.nih.gov
@helenvmadamba POGS CEBU 2016
71. On February 2, 2016 News reports
of a Dallas County case of
sexually transmitted Zika virus
https://www.youtube.com/watch?v=ubEfwHM0mlA
@helenvmadamba POGS CEBU 2016
72. • In December 2013, during a Zika virus (ZIKV)
outbreak in French Polynesia, a patient in
Tahiti sought treatment for hematospermia,
and ZIKV was isolated from his semen.
• ZIKV transmission by sexual intercourse has
been previously suspected.
• This observation supports the possibility that
ZIKV could be transmitted sexually.
Musso et.al. 2015 at http://www.ncbi.nlm.nih.gov
@helenvmadamba POGS CEBU 2016
73. • Men who reside in or have traveled to
an area of active Zika virus
transmission who have a pregnant
partner should abstain from sexual
activity (i.e. vaginal intercourse, anal
intercourse, or fellatio) for the duration
of the pregnancy.
Oster AM et al 2016 at http://www.cdc.gov/mmwr
@helenvmadamba POGS CEBU 2016
74. • Pope Francis says contraception
is the lesser of two evils.
https://www.youtube.com/watch?v=64ZhdDd6FH4
@helenvmadamba POGS CEBU 2016
76. Mode of Transmission of ZIKV
• Mosquito-borne ZIKV transmission
• Sexual transmission
• Blood transfusion and
transmission of ZIKV
Peterson et.al. 2016 at http://ac.els-cdn.com
@helenvmadamba POGS CEBU 2016
77. Brazil reports Zika infection
from blood transfusions
http://www.reuters.com/article/us-health-zika-brazil-blood-idUSKCN0VD22N
@helenvmadamba POGS CEBU 2016
78. Reduce risk of acquiring ZIKV
• Measures to avoid mosquito bites include
wearing long-sleeved shirts, use of insect
repellant and staying in screened or air-
conditioned accomodations.
• Any travelers who are pregnant or planning
to become pregnant, should avoid travelling
to areas with ZIKV outbreaks.
Peterson et.al. 2016 at http://ac.els-cdn.com
@helenvmadamba POGS CEBU 2016
79. Reduce risk of acquiring ZIKV
• Pregnant women should wear protective
clothing, apply a U.S. Environmental
Protection Agency (EPA)-approved insect
repellant, and sleep in a screened room or
under a mosquito net.
Peterson et.al. 2016 at http://ac.els-cdn.com
@helenvmadamba POGS CEBU 2016
81. WHO Emergency Committee on Zika virus
• A coordinated international response is
needed to improve surveillance, the
detection of infections, congential
malformations, and neurological
complications, to intensify the control of
mosquito populations, and to expedite the
development of diagnostic tests and
vaccines to protect people at risk,
especially during pregnancy
Peterson et.al. 2016 at http://ac.els-cdn.com
@helenvmadamba POGS CEBU 2016
82. DOH, Philippines
• Metro Manila (CNN Philippines):
The Department of Health (DOH)
said it is ready to handle cases of
Zika virus, which is "relatively milder
compared to dengue."
"Yes we are ready," said DOH
spokesman Dr. Lyndon Lee-Suy.
@helenvmadamba POGS CEBU 2016
83. DOH, Philippines
• He added: "But let us clear that not
all pregnant women naman with Zika
would really have babies with
microcephaly.”
• The last recorded Zika virus victim in
the Philippines was in 2012, and he
survived the disease.
@helenvmadamba POGS CEBU 2016
89. References
• Hayes EB. Zika Virus Outside Africa.
Emerging Infectious Diseases Vol. 15, No.
9, September 2009. page 1347-1350.
Accessed on February 23, 2016 at
http://wwwnc.cdc.gov/eid/pdfs/vol15no9_pdf
-version.pdf
90. References
• Roth A, Mercier A, Lepers C, Hoy D,
Duituturaga S, Benyon E, Guillaumot L,
Souarès Y. Concurrent outbreaks of
dengue, chikungunya and Zika virus
infections – an unprecedented epidemic
wave of mosquito-borne viruses in the
Pacific 2012–2014. Euro Surveill.
2014;19(41):pii=20929. Accessed on
February 23, 2016 at
http://www.eurosurveillance.org/ViewArticle.
aspx?ArticleId=20929
91. References
• Musso. Zika Virus Transmission from
French Polynesia to Brazil. Emerging
Infectious Diseases Vol. 21, No. 10,
October 2015, page 1887. Accessed on
February 23, 2016 at
http://wwwnc.cdc.gov/eid/article/21/10/15-
1125_article
92. References
• Alera MT, Hermann L, Tac-An IA,
Klungthong C, Rutvisuttinunt W,
Manasatienkij W, Villa D, Thisomboonsuk
B, Velasco JM, Chinnawirotpisan P, Lago
CB, Roque VG Jr, Macareo LR,
Srikiatkhachorn A, Fernandez S, Yoon I.
Zika Virus Infection, Philippines, 2012.
Emerging Infectious Diseases Vol. 21, No.
4, April 2015 accessed on February 23,
2016 at
http://www.ncbi.nlm.nih.gov/pmc/articles/PM
C4378478/
93. References
• Petersen E, et al. Unexpected and Rapid
Spread of Zika Virus in The Americas -
Implications for Public Health Preparedness
for Mass Gatherings at the 2016 Brazil
Olympic Games. Int J Infect Dis (2016).
Accessed on February 23, 2016 at
http://ac.els-
cdn.com/S1201971216000217/1-s2.0-
S1201971216000217-
main.pdf?_tid=a142cdc6-dc19-11e5-8574-
00000aacb361&acdnat=1456444014_f7624
2858baeb56d6bb8ee290f6ec1da
94. References
• Brito C. Zika Virus: a New Chapter in the
History of Medicine. Acta Med Port 2015
Nov-Dec; 28 (6):679-680. Accessed on
February 23, 2016 at
http://www.actamedicaportuguesa.com/revi
sta/index.php/amp/article/view/7341/4565
95. References
• Schuler-Faccini L, Ribeiro EM, Feitosa IM,
et al. Possible Association Between Zika
Virus Infection and Microcephaly — Brazil,
2015. MMWR Morb Mortal Wkly Rep
2016;65:59–62. Accessed on February 20,
2016 at
http://www.cdc.gov/mmwr/volumes/65/wr/m
m6503e2.htm
96. References
• Petersen EE, Staples JE, Meaney-Delman,
D, et al. Interim Guidelines for Pregnant
Women During a Zika Virus Outbreak —
United States, 2016. MMWR Morb Mortal
Wkly Rep 2016;65:30–33.accessed on
February 23, 2016 at
http://www.cdc.gov/mmwr/volumes/65/wr/m
m6505e2.htm?s_cid=mm6505e2.htm_w
97. References
• Oduyebo T, Petersen EE, Rasmussen SA,
et al. Update: Interim Guidelines for Health
Care Providers Caring for Pregnant Women
and Women of Reproductive Age with
Possible Zika Virus Exposure — United
States, 2016. MMWR Morb Mortal Wkly
Rep 2016;65:122–127 accessed on
February 23, 2016 at
http://www.cdc.gov/mmwr/volumes/65/wr/m
m6505e2.htm?s_cid=mm6505e2.htm_w
98. References
• Staples JE, Dziuban EJ, Fischer M, et al.
Interim Guidelines for the Evaluation and
Testing of Infants with Possible Congenital
Zika Virus Infection — United States, 2016.
MMWR Morb Mortal Wkly Rep 2016;65:63–
67. Accessed on February 23, 2016 at
http://www.cdc.gov/mmwr/volumes/65/wr/m
m6503e3.htm
99. References
• Foy BD, Kobylinski KC, Foy JLC, Blitvich
BJ, Travassos da Rosa A, Haddow AD, et
al. Probable non–vector-borne transmission
of Zika virus, Colorado, USA. Emerg Infect
Dis. 2011 May. Accessed February 26,
2016 at
http://www.ncbi.nlm.nih.gov/pmc/articles/PM
C3321795/pdf/10-1939_finalD.pdf
100. References
• Musso D, Roche C, Robin E, Nhan
T, Teissier A, Cao-Lormeau VM. 2015
Potential sexual transmission of Zika virus.
Emerg Infect Dis. 2015 Feb;21(2):359-61.
Accessed February 26, 2016 at
http://www.ncbi.nlm.nih.gov/pmc/articles/PM
C4313657/
101. References
• DOH ready for Zika virus, February 2, 2016
on CNN Philippines accessed on February
23, 2016 at
http://cnnphilippines.com/news/2016/02/01/
doh-ready-zika-virus.html
102. Helen V. Madamba, MD MPH-TM FPOGS FPIDSOG
February 26, 2016
POGS Cebu Chapter
INFECTION IN PREGNANCY
@helenvmadamba POGS CEBU 2016
103. #HealthXPH tweetchat
Let’s talk about ZIKA!
Saturday, February 27, 2016
9:00 p.m. to 10:00 p.m. MLA
@helenvmadamba
https://www.facebook.com/Helen-V-Madamba
http://www.slideshare.net/HelenMadamba
INFECTION IN PREGNANCY
@helenvmadamba POGS CEBU 2016
Editor's Notes
Reverse transcription-PCR testing for symptomatic patients with onset of symptoms during the previous week
Immunoglobulin M (IgM) and plaque-reduction neutralizing antibody testing should be performed on specimens ≥4 days after onset of symptoms
FIGURE 1. Updated Interim guidance: testing algorithm*,†,§,¶,** for a pregnant woman with history of travel to an area with ongoing Zika virus transmission
* Testing is recommended for pregnant women with clinical illness consistent with Zika virus disease, which includes two or more of the following signs or symptoms: acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis during or within 2 weeks of travel. Testing includes Zika virus reverse transcription-polymerase chain reaction (RT-PCR), and Zika virus immunoglobulin M (IgM) and neutralizing antibodies on serum specimens (http://www.aphl.org/Materials/CDCMemo_Zika_Chik_Deng_Testing_011916.pdf). Because of the overlap of symptoms and areas where other viral illnesses are endemic, evaluation for dengue or chikungunya virus infection is also recommended.
† Testing can be offered to pregnant women without clinical illness consistent with Zika virus disease. If performed, testing should include Zika virus IgM, and if IgM test result is positive or indeterminate, neutralizing antibodies on serum specimens. Testing should be performed 2–12 weeks after travel.
§ Laboratory evidence of maternal Zika virus infection: 1) Zika virus RNA detected by RT-PCR in any clinical specimen; or 2) positive Zika virus IgM with confirmatory neutralizing antibody titers that are ≥4-fold higher than dengue virus neutralizing antibody titers in serum. Testing is considered inconclusive if Zika virus neutralizing antibody titers are <4-fold higher than dengue virus neutralizing antibody titers.
¶ Fetal ultrasounds might not detect microcephaly or intracranial calcifications until the late second or early third trimester of pregnancy.
** Amniocentesis is not recommended until after 15 weeks of gestation. Amniotic fluid should be tested for Zika virus RNA by RT-PCR. The sensitivity and specificity of RT-PCR testing on amniotic fluid are not known.
FIGURE 2. Interim guidance: testing algorithm*,†,§,¶,** for a pregnant woman residing in an area with ongoing Zika virus transmission,†† with or without clinical illness consistent with Zika virus disease§§
* Tests for pregnant women with clinical illness consistent with Zika virus disease include Zika virus reverse transcription-polymerase chain reaction (RT-PCR), and Zika virus immunoglobulin M (IgM) and neutralizing antibodies on serum specimens (http://www.aphl.org/Materials/CDCMemo_Zika_Chik_Deng_Testing_011916.pdf). Because of the overlap of symptoms and areas where other viral illnesses are endemic, evaluation for dengue or chikungunya virus infection is also recommended. If chikungunya or dengue virus RNA is detected, treat in accordance with existing guidelines. Timely recognition and supportive treatment for dengue virus infections can substantially lower the risk of medical complications and death. Repeat Zika virus testing during pregnancy is warranted if clinical illness consistent with Zika virus disease develops later in pregnancy.
† Testing can be offered to pregnant women without clinical illness consistent with Zika virus disease. If performed, testing should include Zika virus IgM, and if IgM test result is positive or indeterminate, neutralizing antibodies on serum specimens. Results from serologic testing are challenging to interpret in areas where residents have had previous exposure to other flaviviruses (e.g., dengue, yellow fever).
§ Laboratory evidence of maternal Zika virus infection: 1) Zika virus RNA detected by RT-PCR in any clinical specimen; or 2) positive Zika virus IgM with confirmatory neutralizing antibody titers that are ≥4-fold higher than dengue virus neutralizing antibody titers in serum. Testing is considered inconclusive if Zika virus neutralizing antibody titers are <4-fold higher than dengue virus neutralizing antibody titer.
¶ Amniocentesis is not recommended until after 15 weeks gestation. Amniotic fluid should be tested for Zika virus RNA by RT-PCR. The sensitivity and specificity of RT-PCR testing on amniotic fluid are not known.
** Fetal ultrasounds might not detect microcephaly or intracranial calcifications until the late second or early third trimester of pregnancy.
†† Local health officials should determine when to implement testing of asymptomatic pregnant women based on information about levels of Zika virus transmission and laboratory capacity.
§§ Clinical illness consistent with Zika virus disease is defined as two or more of the following signs or symptoms: acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis.
FIGURE 2. Interim guidance: testing algorithm*,†,§,¶,** for a pregnant woman residing in an area with ongoing Zika virus transmission,†† with or without clinical illness consistent with Zika virus disease§§
* Tests for pregnant women with clinical illness consistent with Zika virus disease include Zika virus reverse transcription-polymerase chain reaction (RT-PCR), and Zika virus immunoglobulin M (IgM) and neutralizing antibodies on serum specimens (http://www.aphl.org/Materials/CDCMemo_Zika_Chik_Deng_Testing_011916.pdf). Because of the overlap of symptoms and areas where other viral illnesses are endemic, evaluation for dengue or chikungunya virus infection is also recommended. If chikungunya or dengue virus RNA is detected, treat in accordance with existing guidelines. Timely recognition and supportive treatment for dengue virus infections can substantially lower the risk of medical complications and death. Repeat Zika virus testing during pregnancy is warranted if clinical illness consistent with Zika virus disease develops later in pregnancy.
† Testing can be offered to pregnant women without clinical illness consistent with Zika virus disease. If performed, testing should include Zika virus IgM, and if IgM test result is positive or indeterminate, neutralizing antibodies on serum specimens. Results from serologic testing are challenging to interpret in areas where residents have had previous exposure to other flaviviruses (e.g., dengue, yellow fever).
§ Laboratory evidence of maternal Zika virus infection: 1) Zika virus RNA detected by RT-PCR in any clinical specimen; or 2) positive Zika virus IgM with confirmatory neutralizing antibody titers that are ≥4-fold higher than dengue virus neutralizing antibody titers in serum. Testing is considered inconclusive if Zika virus neutralizing antibody titers are <4-fold higher than dengue virus neutralizing antibody titer.
¶ Amniocentesis is not recommended until after 15 weeks gestation. Amniotic fluid should be tested for Zika virus RNA by RT-PCR. The sensitivity and specificity of RT-PCR testing on amniotic fluid are not known.
** Fetal ultrasounds might not detect microcephaly or intracranial calcifications until the late second or early third trimester of pregnancy.
†† Local health officials should determine when to implement testing of asymptomatic pregnant women based on information about levels of Zika virus transmission and laboratory capacity.
§§ Clinical illness consistent with Zika virus disease is defined as two or more of the following signs or symptoms: acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis.
FIGURE 2. Interim guidance: testing algorithm*,†,§,¶,** for a pregnant woman residing in an area with ongoing Zika virus transmission,†† with or without clinical illness consistent with Zika virus disease§§
* Tests for pregnant women with clinical illness consistent with Zika virus disease include Zika virus reverse transcription-polymerase chain reaction (RT-PCR), and Zika virus immunoglobulin M (IgM) and neutralizing antibodies on serum specimens (http://www.aphl.org/Materials/CDCMemo_Zika_Chik_Deng_Testing_011916.pdf). Because of the overlap of symptoms and areas where other viral illnesses are endemic, evaluation for dengue or chikungunya virus infection is also recommended. If chikungunya or dengue virus RNA is detected, treat in accordance with existing guidelines. Timely recognition and supportive treatment for dengue virus infections can substantially lower the risk of medical complications and death. Repeat Zika virus testing during pregnancy is warranted if clinical illness consistent with Zika virus disease develops later in pregnancy.
† Testing can be offered to pregnant women without clinical illness consistent with Zika virus disease. If performed, testing should include Zika virus IgM, and if IgM test result is positive or indeterminate, neutralizing antibodies on serum specimens. Results from serologic testing are challenging to interpret in areas where residents have had previous exposure to other flaviviruses (e.g., dengue, yellow fever).
§ Laboratory evidence of maternal Zika virus infection: 1) Zika virus RNA detected by RT-PCR in any clinical specimen; or 2) positive Zika virus IgM with confirmatory neutralizing antibody titers that are ≥4-fold higher than dengue virus neutralizing antibody titers in serum. Testing is considered inconclusive if Zika virus neutralizing antibody titers are <4-fold higher than dengue virus neutralizing antibody titer.
¶ Amniocentesis is not recommended until after 15 weeks gestation. Amniotic fluid should be tested for Zika virus RNA by RT-PCR. The sensitivity and specificity of RT-PCR testing on amniotic fluid are not known.
** Fetal ultrasounds might not detect microcephaly or intracranial calcifications until the late second or early third trimester of pregnancy.
†† Local health officials should determine when to implement testing of asymptomatic pregnant women based on information about levels of Zika virus transmission and laboratory capacity.
§§ Clinical illness consistent with Zika virus disease is defined as two or more of the following signs or symptoms: acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis.